Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Oct 26, 2026

Press release

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM, “Tempus”) today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY, “BMS”), under which BMS will license multimodal oncology data from Tempus through 2031 to support biological and clinical insight identification, novel drug target discovery and therapeutic development across its oncology portfolio. With this agreement, BMS significantly expands its strategic relationship with Tempus and becomes one of Tempus’s largest li
Press release cover image

Oct 26, 2026

Press release

Pathos AI Announces Strategic Collaborations with Bristol Myers Squibb and Tempus AI to Advance AI-Driven Drug Development Beginning with Alzheimer’s Disease and Other Neurological Conditions

Tempus to build a de-identified dataset from hundreds of thousands of patients with neurological conditions; Pathos to license the dataset under a five-year, $55 million agreementPathos’s AI expertise and agentic AI platform, Foundry, combined with Bristol Myers Squibb’s (BMS) neuroscience drug development expertise to be applied to understanding disease progression and advancing new therapiesBMS leads Pathos’s Series E financing and gains non-exclusive strategic access to Pathos’s AI platform,
Ambulance merging into hospital silhouette

Oct 26, 2026

NSW digitises ambulance-to-hospital patient handovers

eHealth NSW is enhancing the efficiency of patient handovers between ambulances and hospitals through a new digital integration, significantly reducing the time needed for clinicians to access vital paramedic information.The initiative merges the NSW Ambulance electronic medical record (EMR) system with the Ambulance Arrivals Board, allowing emergency department (ED) clinicians to access paramedic records promptly. This system minimizes reliance on traditional paper records, streamlining the han
A minimalist illustration of a laboratory flask and an AI chip in flat design.

Oct 24, 2026

Danaher, NVIDIA, FedEx, Sanofi: This Week in Healthcare

This week in healthcare highlights significant advancements in AI integration, strategic mergers, and manufacturing innovations that are shaping the industry landscape.Danaher is intensifying its focus on AI-driven scientific advancements through a new partnership with NVIDIA. This collaboration aims to merge Danaher's laboratory technologies and expertise with NVIDIA's AI capabilities, facilitating a streamlined process where computational predictions can rapidly transition to experimental vali
A blood sample in a test tube on a lab bench

Oct 24, 2026

Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach

Quest Diagnostics has confirmed a significant data breach affecting sensitive patient information due to a cyberattack on its Quanum system, which is integral for lab testing and billing processes in healthcare settings.The company disclosed the breach in an 8-K filing with the U.S. Securities and Exchange Commission, indicating that unauthorized access to certain patient records occurred. Quest has initiated an investigation and notified law enforcement but has not specified the extent of the d
A minimalist illustration of a pill and tablet in a dark palette.

Oct 24, 2026

Altimetrik opens Healthcare & Life Sciences Center of Excellence in Hyderabad

Altimetrik has established a new Healthcare & Life Sciences Center of Excellence in Hyderabad, aimed at driving AI innovation within the sector.This facility's inaugural offering, PharmaOS, is an advanced AI platform tailored for life sciences. It is designed to assist organizations in swiftly developing and validating AI-driven workflows, transitioning from conceptual ideas to operational use cases in just one week. The Center of Excellence will focus on building compliant AI agents that ensure
A chest X-ray and stethoscope in a clinical setting

Oct 24, 2026

Artificial Intelligence Advances Precision Cardiovascular Care

Recent advancements in artificial intelligence (AI) are significantly enhancing precision in cardiovascular care, as highlighted in a new editorial in Open Heart. The piece discusses the promising applications of AI in diagnostics, risk assessment, and clinical decision-making, aiming to bridge the gap between algorithmic development and practical implementation in healthcare settings.AI technologies are revolutionizing cardiovascular diagnostics by augmenting traditional tools. For instance, de
A minimalist representation of herbal medicine and digital technology.

Oct 24, 2026

Ancient Chinese Preventive Medicine Meets AI in Proposed Digital Health Framework

A novel framework proposed by researchers at Quzhou Hospital of Traditional Chinese Medicine aims to integrate ancient TCM principles with modern digital technologies to enhance preventive healthcare.The researchers advocate for a shift from traditional reactive medical practices to a preventive model, emphasizing the TCM philosophy of addressing health issues before they manifest. This framework is particularly relevant as non-communicable diseases account for a significant majority of global m
Press release cover image

Oct 24, 2026

Press release

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment BiologySEOUL, South Korea, Oct. 24, 2026 /PRNewswire/ -- Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use of Lunit SCOPE IO, Lunit's AI-powered pathology platform, for tumor microenvironment analysis in support of Summit's immuno-oncology development programs with ivone
Press release cover image

Oct 23, 2026

Press release

Quest Diagnostics Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Unauthorized Access to Patient Records

National class action law firm offers free, confidential case evaluations to Quest Diagnostics patients and others whose information may have been exposed.SECAUCUS, N.J., Oct. 23, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a data breach at Quest Diagnostics, a Secaucus, New Jersey-based clinical diagnostic laboratory company and one of the largest lab testing providers in the United States. Anyone who received a
Press release cover image

Oct 23, 2026

Press release

Biointron Introduces RushDATA™ to Accelerate Wet-Lab Validation for AI-Driven Antibody Discovery

· 1-day CHO expression and rapid characterization help close the gap between computational design and experimental validation· 20,000+ molecules per week capacity supports large-scale screening of AI-generated antibody candidates· Integrated binding and developability assessments generate standardized, multidimensional datasets for candidate selection and AI/ML workflowsCAMBRIDGE, Mass.--(BIOSPACE)-- Biointron BiologicalUSA Inc. ("Biointron"), a leading contract research organizationspecializing
Press release cover image

Oct 23, 2026

Press release

BioVid Launches Mimetics™, AI Research Audiences Built on How Physicians Reason and Decide

Modeling physician response patterns and behavior, showing an 80–90% match with real physicians on content, reasoning, and emotion. BRISTOL, Pa., Oct. 23, 2026 /PRNewswire/ -- BioVid, a life science consultancy, today announced the launch of BioVid Mimetics™, a research platform that gives pharmaceutical teams mimetics: synthetic physician audiences modeled on how those audiences reason and decide. Its respondent models are grounded in BioVid's proprietary MindSet Modeling™ program, large-scale,